Reflex Sympathetic Dystrophy Syndrome Education

Act 62 of 2003, § 4, under REFLEX SYMPATHETIC DYSTROPHY SYNDROME EDUCATION ACT - ENACTMENT.

Act 62 of 2003, § 4

Section 4. Reflex Sympathetic Dystrophy Syndrome Education

Program.

(a) Establishment.--The department shall establish the Reflex Sympathetic Dystrophy Syndrome Education Program to promote public awareness of the causes of RSDS and the value of early detection, diagnosis and treatment of this disease.

(b) Duties of department.--The department shall:

(1) Establish a public education and outreach campaign

via written materials and brochures to promote awareness of

RSDS and enable individuals to make informed decisions about

their health, including, but not limited to:

(i) Cause and nature of the disease.

(ii) Risk factors that contribute to the

manifestation of the disease.

(iii) All available treatment options, including

risks and benefits of said options.

(iv) Environmental safety and injury prevention.

(v) Rest and use of appropriate body mechanics.

(vi) Availability of RSDS diagnostic, treatment and

outreach services in the community.

(vii) Any other factors or elements that might

mitigate the effects of this disease.

(2) Develop educational materials and brochures which

shall be made available to consumers through State and local

departments of health, hospitals, clinics and other health

care providers.

(3) Develop relationships with health care providers and

health-related community-based organizations to promote and

coordinate professional education programs on RSDS for,

including, but not limited to:

(i) Research findings.

(ii) Cause and nature of the disease.

(iii) Risk factors, including, but not limited to,

lifestyle, heredity and drug interactions.

(iv) Diagnostic procedures and appropriate

indications for their use.

(v) All medical and surgical treatment options,

including experimental and established drug therapies and

the benefits and risks of each option.

(vi) Environmental safety and injury prevention.

(vii) Availability of RSDS diagnosis, treatment and

support services in the community.